Comparison 36. Exposure to clomiphene; comparison group: general population; any; follow‐up>10 years.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Endometrial cancer; subgroup by effect estimate | 3 | 18931 | Risk Ratio (Random, 95% CI) | 2.08 [1.01, 4.28] |
1.1 SIR | 2 | 4106 | Risk Ratio (Random, 95% CI) | 1.61 [0.79, 3.29] |
1.2 HR | 1 | 14825 | Risk Ratio (Random, 95% CI) | 4.56 [1.56, 13.33] |